PURPOSE: To explore a karyotypically abnormal variant human embryonic stem cell (hESC) line, BG01V, as a potential model for studies of dopaminergic neuronal differentiation. METHODS: The properties of BG01V cells were compared to those of normal BG01 cells using immunocytochemistry, RT-PCR, focused microarrays and in vitro differentiation, including dopaminergic differentiation, by culturing with the stromal cell line PA6. RESULTS: Despite the karyotypic abnormality (49, +12, +17 and XXY), undifferentiated BG01V cells expressed pluripotent ESC markers similar to BG01 cells, and retained the ability to differentiate into cell types characteristic of all three germ layers. When co-cultured with the stromal cell line PA6, BG01V cells differentiated into dopaminergic cells which exhibited properties similar to those of mature dopaminergic neurons. CONCLUSIONS: BG01V cells were easier to maintain in culture than karyotypically normal BG01 cells and can be used as an alternative pluripotent hESC type for in vitro developmental studies.
PURPOSE: To explore a karyotypically abnormal variant human embryonic stem cell (hESC) line, BG01V, as a potential model for studies of dopaminergic neuronal differentiation. METHODS: The properties of BG01V cells were compared to those of normal BG01 cells using immunocytochemistry, RT-PCR, focused microarrays and in vitro differentiation, including dopaminergic differentiation, by culturing with the stromal cell line PA6. RESULTS: Despite the karyotypic abnormality (49, +12, +17 and XXY), undifferentiated BG01V cells expressed pluripotent ESC markers similar to BG01 cells, and retained the ability to differentiate into cell types characteristic of all three germ layers. When co-cultured with the stromal cell line PA6, BG01V cells differentiated into dopaminergic cells which exhibited properties similar to those of mature dopaminergic neurons. CONCLUSIONS: BG01V cells were easier to maintain in culture than karyotypically normal BG01 cells and can be used as an alternative pluripotent hESC type for in vitro developmental studies.
Authors: Marina Bibikova; Eugene Chudin; Bonnie Wu; Lixin Zhou; Eliza Wickham Garcia; Ying Liu; Soojung Shin; Todd W Plaia; Jonathan M Auerbach; Dan E Arking; Rodolfo Gonzalez; Jeremy Crook; Bruce Davidson; Thomas C Schulz; Allan Robins; Aparna Khanna; Peter Sartipy; Johan Hyllner; Padmavathy Vanguri; Smita Savant-Bhonsale; Alan K Smith; Aravinda Chakravarti; Anirban Maitra; Mahendra Rao; David L Barker; Jeanne F Loring; Jian-Bing Fan Journal: Genome Res Date: 2006-08-09 Impact factor: 9.043
Authors: Tandis Vazin; Jia Chen; Charles E Spivak; Rose Amable; Emily Gabitzsch; Chun-Ting Lee; Carl R Lupica; William J Freed Journal: Restor Neurol Neurosci Date: 2008 Impact factor: 2.406
Authors: Hye Won Seol; Sun Kyung Oh; Yong Bin Park; Hee Sun Kim; Jin Ah Baek; Jin Seo; Eun Hee Kim; Seung Yup Ku; Seok Hyun Kim; Young Min Choi; Shin Yong Moon Journal: Chromosome Res Date: 2008-10-22 Impact factor: 5.239
Authors: Franz-Josef Müller; Louise C Laurent; Dennis Kostka; Igor Ulitsky; Roy Williams; Christina Lu; In-Hyun Park; Mahendra S Rao; Ron Shamir; Philip H Schwartz; Nils O Schmidt; Jeanne F Loring Journal: Nature Date: 2008-08-24 Impact factor: 49.962